Cyclerion Therapeutics CYCN
NASDAQ CYCN
$4.07 -0.06 (-1.45%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cyclerion Therapeutics (CYCN) EPS (Diluted) (2021 - 2025)

Cyclerion Therapeutics (CYCN) EPS (Diluted) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Cyclerion Therapeutics 13.45 Mn 10.21 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.31
Jun 30, 2025 -0.54
Mar 31, 2025 -0.57
Sep 30, 2023 4.84
Jun 30, 2023 -1.04
Mar 31, 2023 -1,731.16
Dec 31, 2022 -1.33
Sep 30, 2022 -2.80
Jun 30, 2022 -6.27
Mar 31, 2022 -6,072.78
Dec 31, 2021 -8.03
Sep 30, 2021 -5.62
Jun 30, 2021 -10.36